Abstract
The role of Mycoplasma hominis as a causative agent for neonatal sepsis and meningitis is still unclear. Meningitis secondary to M. hominis is well-described in the literature; however, M. hominis can also be isolated from cerebrospinal fluid (CSF) obtained from infants without signs of meningitis. We present a case of a full-term infant with meningo-encephalitis with seizures, epileptic activity on the EEG, inflammation of brain tissue on a CT scan, and cloudy CSF containing elevated cell counts, decreased glucose levels and elevated protein levels. M. hominis was identified from the CSF by culture and by polymerase chain reaction (PCR) as the only possible causative agent. Furthermore, while empiric antibiotic and antiviral treatment for neonatal sepsis had failed, the meningo-encephalitis promptly responded upon antibiotic treatment with ciprofloxacin (20 mg/kg per day i.v.), to which M. hominis is susceptible. Conclusion: a meningo-encephalitis developed due to infection with M. hominis in a full-term infant, from which he recovered rapidly after start of treatment with ciprofloxacin.
Similar content being viewed by others
References
Alonso-Vega C, Wauters N, Vermeylen D, Muller MF, Serruys E (1997) A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn. J Clin Microbiol 35: 286–287
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402
Burkhardt JE, Walterspiel JN, Schaad UB (1997) Quinolone arthropathy in animals versus children. Clin Infect Dis 25: 1196–1204
Cassell GH, Waites KB, Crouse DT (2001) Mycoplasmal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. Saunders, Philadelphia, pp 733–767
Dosa E, Nagy E, Falk W, Szoke I, Ballies U (1999) Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum. J Antimicrob Chemother 43: 575–578
Gewitz M, Dinwiddie R, Rees L, Volikas O, Yuille T, O'Connell B, Marshall WC (1979) Mycoplasma hominis. A cause of neonatal meningitis. Arch Dis Child 54: 231–233
Kenny GE, Cartwright FD (2001) Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 45: 2604–2608
Kirk N, Kovar I (1987) Mycoplasma hominis meningitis in a preterm infant. J Infect 15: 109–110
Likitnukul S, Kusmiesz H, Nelson JD, McCracken GH Jr (1986) Role of genital mycoplasmas in young infants with suspected sepsis. J Pediatr 109: 971–974
McCormack WM (1993) Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin Infect Dis 17[Suppl 1]: S200–S201
McDonald JC, Moore DL (1988) Mycoplasma hominis meningitis in a premature infant. Pediatr Infect Dis J 7: 795–798
McNaughton RD, Robertson JA, Ratzlaff VJ, Molberg CR (1983) Mycoplasma hominis infection of the central nervous system in a neonate. Can Med Assoc J 129: 353–354
Schaad UB (1999) Pediatric use of quinolones. Pediatr Infect Dis J 18: 469–470
Siber GR, Alpert S, Smith AL, Lin JS, McCormack WM (1977) Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr 90: 625–627
Taylor-Robinson D (2000) Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2027–2032
Ullmann U, Schubert S, Krausse R (1999) Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 43[Suppl C]: 33–36
Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L, Hammerschlag MR (1993) Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr Infect Dis J 12: 571–573
Waites KB, Canupp KC, Kenny GE (1999) In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother 43: 2571–2573
Waites KB, Duffy LB, Crouse DT, Dworsky ME, Strange MJ, Nelson KG, Cassell GH (1990) Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 9: 241–245
Wealthall SR (1975) Mycoplasma meningitis in infants with spina bifida. Dev Med Child Neurol Suppl 35: 117–122
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wolthers, K.C., Kornelisse, R.F., Platenkamp, G.J.J.M. et al. A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin. Eur J Pediatr 162, 514–516 (2003). https://doi.org/10.1007/s00431-003-1219-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-003-1219-6